"The new global study, published in JAMA Network Open, reviewed 110 randomized clinical trials involving more than 22,000 patients who received cefepime or another beta-lactam antibiotic — a class of drugs that includes penicillins and cephalosporins."
Framing: mixed ·
First seen: 2026-09-16 ·
Last seen: 2026-09-16 ·
Spread: 1 articles